BBMCT’s primary client is the small to mid-size biopharma company who is looking to partner under a full-service model where our medical, regulatory and operational expertise can help accelerate development. Our culture and our operating structure are purposely designed to accommodate efficient partnering, important for emerging biotech’s with limited resources and sometimes limited experience. As a mid-sized CRO with global capabilities, BBMCT is big enough to manage challenging trials of all sizes, yet small enough to give you the attention and focus demanded by your stakeholders.
Challenging science coupled with complex regulatory frameworks require an experienced CRO. Selecting the appropriate partner with drug development expertise and regulatory experience is crucial to ensure robust study designs and to facilitate efficient clinical trial execution, as well as impactful agency and site interactions, and regulatory submissions. It is critical to have advanced knowledge of the disease, endpoints, sites, patient access and so on.
British BioMedicine Clinical Trials (BBMCT)
As drug development continues to become more complex with advances in immuno-therapies, gene and cell therapies, and microbiome therapeutics as examples, experience in a specific indication is no longer as critical for running clinical trials. BBMCT can apply its medical and regulatory foundation across therapeutic areas and diseases, rare diseases and orphan indications, as well as leading technologies and platforms to optimize your study. This “cross-pollination” of expertise allows us to apply our experience and relationships to an extensive range of diseases.
BBMCT’s depth of medical, regulatory, and operational expertise—as well as wholly-owned integrated labs and imaging—provides the resources and services that enrich and strengthen your team. In a continuously changing and challenging industry, flexibility and problem solving are critical. BBMCT’s ability to adapt to unexpected problems and a streamlined decision-making structure helps keep clinical development on track. Your project team will be led by medical, regulatory and operational experts with deep therapeutic experience who are fully engaged throughout your study, proving guidance and averting potential roadblocks by staying close to the project.
